|
RBM27 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.808620E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.01820000000197E-05 |
| Normal-vs-Stage2 |
3.925800E-02 |
| Normal-vs-Stage3 |
4.124600E-01 |
| Normal-vs-Stage4 |
8.982600E-01 |
| Stage1-vs-Stage2 |
8.423400E-01 |
| Stage1-vs-Stage3 |
8.724000E-02 |
| Stage1-vs-Stage4 |
7.514100E-02 |
| Stage2-vs-Stage3 |
2.762600E-01 |
| Stage2-vs-Stage4 |
1.959580E-01 |
| Stage3-vs-Stage4 |
5.661200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.791400E-04 |
| Normal-vs-AfricanAmerican |
7.029100E-04 |
| Normal-vs-Asian |
5.200300E-02 |
| Caucasian-vs-AfricanAmerican |
6.871000E-01 |
| Caucasian-vs-Asian |
9.107800E-01 |
| AfricanAmerican-vs-Asian |
9.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.01950000003437E-06 |
| Normal-vs-Female |
4.942600E-01 |
| Male-vs-Female |
2.761300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.815760E-02 |
| Normal-vs-Extreme_Weight |
2.44389999999317E-05 |
| Normal-vs-Obese |
5.747900E-02 |
| Normal-vs-Extreme_Obese |
1.361630E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.590600E-01 |
| Normal_Weight-vs-Obese |
4.187200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.448000E-01 |
| Extreme_Weight-vs-Obese |
5.879900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.832400E-01 |
| Obese-vs-Extreme_Obese |
2.262800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.584800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.892300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.68489999963617E-07 |
| Normal-vs-Age(81-100Yrs) |
6.22049999999819E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.758800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.083230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.270000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.639200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.051990E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.326400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.55470000004787E-06 |
| Normal-VS-Type2 PRCC |
1.244070E-02 |
| Normal-VS-KIRP CIMP |
8.051000E-01 |
| Normal-VS-Unclassified PRCC |
4.923200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.380800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.091190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.815900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.629400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.929600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.515000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.09679999999746E-05 |
| Normal-vs-N1 |
6.614800E-01 |
| Normal-vs-N2 |
7.113200E-01 |
| N0-vs-N1 |
1.796370E-03 |
| N0-vs-N2 |
3.209000E-01 |
| N1-vs-N2 |
6.036600E-01 |
|
|
